Location History:
- Toronto, CA (2016)
- Willowdale, CA (2004 - 2024)
Company Filing History:
Years Active: 2004-2024
Title: Innovations of George Peter Darmos
Introduction
George Peter Darmos is a notable inventor based in Willowdale, CA, recognized for his contributions to the field of medical technology. With a total of five patents to his name, Darmos has made significant advancements in radiofrequency ablation techniques, which are crucial for various therapeutic applications.
Latest Patents
Darmos's latest patents include a "Method and apparatus for precisely controlling the size and shape of radiofrequency ablations." This invention describes various embodiments of multielectrode radiofrequency (RF) ablation probes that enhance control and predictability of RF thermal electrocoagulations. The invention allows for irregularly shaped ablations to conform to target tissue volumes and enables large ablations without the need for electrode cooling. Another notable patent is the "Radiofrequency probes with retractable multi-tined electrodes." This retractable RF probe is designed for applying RF energy to tissue for therapeutic purposes. It features a tubular elongate member with a handle element and an electrode element that includes a tip portion and multiple tines, which can be retracted or deployed as needed.
Career Highlights
Throughout his career, Darmos has worked with several companies, including Diros Technology Inc. and Z-Tech (Canada) Inc. His work in these organizations has contributed to the development of innovative medical devices and technologies.
Collaborations
Darmos has collaborated with various professionals in his field, including Ilya Gavrilov and Peter George Darmos. These collaborations have fostered a creative environment that has led to the development of groundbreaking technologies.
Conclusion
George Peter Darmos is a distinguished inventor whose work in radiofrequency ablation technology has made a significant impact in the medical field. His innovative patents and collaborations highlight his commitment to advancing medical technology for therapeutic purposes.